Funding: The project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (grant number: 12/142/07) and will be published in full in Health Technology Assessment. The funder was not involved in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication. The Health Services Research Unit (HSRU) and the Health Economics Research Unit (HERU) are core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorate (HSRU/2021-2024, HERU/2021-2024).Peer reviewedPostprin
BackgroundPatients with neovascular age-related macular degeneration (nAMD) usually attend regular r...
Purpose: To analyse the development of neovascular age-related macular degeneration (nAMD) in the fe...
Importance: Detection of early onset neovascular age-related macular degeneration (AMD) is critical ...
Background/aims To evaluate the cost-effectiveness of non-invasive monitoring tests to detect the on...
Funding This project was funded by the National Institute for Health Research (NIHR) Health Technolo...
Funding Information: The author(s) have made the following disclosure(s): R.G.: Personal fees ? Heid...
Background: Age-related macular degeneration is the most common cause of sight impairment in the UK....
Results: In pooled estimates of diagnostic studies (all TD-OCT), sensitivity and specificity [95% co...
Abstract BACKGROUND: Age-related macular degeneration is the most common cause of sight impairment i...
OBJECTIVE: Predicting the impact of neovascular age-related macular degeneration (nAMD) service disr...
Background: Patients with neovascular age-related macular degeneration (nAMD) usually attend regular...
Objective Management of age-related macular degeneration (AMD) places a high demand on already const...
Results: In pooled estimates of diagnostic studies (all TD-OCT), sensitivity and specificity [95% co...
PURPOSE: Management of neovascular age-related macular degeneration (nAMD) has evolved over the last...
Objectives To assess the cost-effectiveness of optometrist-led follow-up monitoring reviews for pati...
BackgroundPatients with neovascular age-related macular degeneration (nAMD) usually attend regular r...
Purpose: To analyse the development of neovascular age-related macular degeneration (nAMD) in the fe...
Importance: Detection of early onset neovascular age-related macular degeneration (AMD) is critical ...
Background/aims To evaluate the cost-effectiveness of non-invasive monitoring tests to detect the on...
Funding This project was funded by the National Institute for Health Research (NIHR) Health Technolo...
Funding Information: The author(s) have made the following disclosure(s): R.G.: Personal fees ? Heid...
Background: Age-related macular degeneration is the most common cause of sight impairment in the UK....
Results: In pooled estimates of diagnostic studies (all TD-OCT), sensitivity and specificity [95% co...
Abstract BACKGROUND: Age-related macular degeneration is the most common cause of sight impairment i...
OBJECTIVE: Predicting the impact of neovascular age-related macular degeneration (nAMD) service disr...
Background: Patients with neovascular age-related macular degeneration (nAMD) usually attend regular...
Objective Management of age-related macular degeneration (AMD) places a high demand on already const...
Results: In pooled estimates of diagnostic studies (all TD-OCT), sensitivity and specificity [95% co...
PURPOSE: Management of neovascular age-related macular degeneration (nAMD) has evolved over the last...
Objectives To assess the cost-effectiveness of optometrist-led follow-up monitoring reviews for pati...
BackgroundPatients with neovascular age-related macular degeneration (nAMD) usually attend regular r...
Purpose: To analyse the development of neovascular age-related macular degeneration (nAMD) in the fe...
Importance: Detection of early onset neovascular age-related macular degeneration (AMD) is critical ...